市場調查報告書
商品編碼
1541024
2024-2032 年按產品應用、最終用戶和地區分類的旋切設備市場報告Atherectomy Devices Market Report by Product Application, End User, and Region 2024-2032 |
IMARC Group年,全球旋切設備市場規模達9.78億美元。周邊動脈疾病(PAD)的增加、重大技術進步、人口老化、微創手術的出現、醫療保健基礎設施的發展以及新興經濟體的報銷政策是推動斑塊切除術市場成長的一些關鍵因素。
主要市場促進因素:旋切設備市場受到周邊動脈疾病(PAD)和其他心血管疾病病例不斷增加的影響。日益成長的老齡化人口更容易患這些疾病,加上糖尿病、肥胖和吸煙病例的增加,正在對這些設備產生間接需求。此外,斑塊切除術的技術進步和微創手術的日益普及為市場提供了大量機會。
主要市場趨勢:斑塊旋切設備市場正在擴大,主要是由於 PAD 病例的增加和微創手術的需求等重大趨勢。技術的進步使得能夠生產更先進的設備,從而提供更高的準確性和更短的恢復週期。定向粥樣斑塊切除系統也越來越受歡迎,因為它們允許使用者在不損壞血管壁的情況下瞄準並去除動脈粥狀硬化斑塊。在新興經濟體,醫療基礎設施的發展和更好的報銷情況正在推動斑塊切除設備在全球範圍內的可用性和使用。
競爭格局:斑塊切除設備產業的一些主要市場參與者包括 Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、CR Bard (Becton、Dickinson and Company)、Cardinal Health、Koninklijke Philips NV 、Medtronic、Minnetronix Inc.、Straub Medical AG(Becton、Dickinson and Company)、Terumo Corporation 等。
挑戰與機會:旋切設備市場面臨多項挑戰,包括高昂的設備成本和嚴格的監管要求,導致產品發布延遲。相反,市場機會也受到周邊動脈疾病發病率上升和人口老化的影響,這導致需要有效的治療替代方案。提高設備性能和安全性的技術發展提供了成長機會。此外,新興市場醫療保健基礎設施的成長創造了新的市場擴張前沿,刺激了全球對斑塊旋切手術的需求。
周邊動脈疾病 (PAD) 病例不斷增加
由於人口老化以及糖尿病和肥胖症的增加,全球 PAD 病例不斷增加,導致斑塊旋切設備市場成長。在美國,PAD 大約影響 8 至 1,200 萬人,尤其是 50 歲以上的人。斑塊切除裝置提供了一種去除動脈斑塊的微創方法,因為它是血管介入治療的重要替代方案。該裝置可增強血液流動並減輕腿部疼痛和疲勞等症狀。透過直接切除或蒸發斑塊,這些設備有助於恢復動脈通暢,顯著改善患有嚴重周邊動脈疾病的患者的治療效果。
技術進步
主要的旋切設備創新包括定向控制設備和高頻旋轉技術的出現,這些技術不斷提高了這些設備的有效性和安全性。例如,2020 年的一項研究表明,眼眶斑塊旋切術(磨碎斑塊)可以在90% 的情況下有效地打開阻塞的腿部動脈,而雷射旋切術可以在76% 的情況下實現類似的血流改善。患者治療效果的改善和外科醫生對這些設備的偏好正在推動斑塊切除設備的成長。在一項涉及 172 名患者的多中心研究中,使用 Jetstream 設備的成功率為 99%,六個月和 12 個月臨床驅動的目標病變血管重建率分別為 15% 和 26%;根據複式成像,一年再狹窄率為 38%。
拓展新興市場
突出的關鍵參與者正在關注醫療基礎設施發展和醫療保健支出成長的新興經濟體,為市場中的關鍵參與者創造新的機會。例如,巴西、俄羅斯、印度、中國和南非(金磚五國)等新興市場正日益影響全球衛生部門醫療產品和服務的供需格局。 2030 年醫療支出佔 GDP 的百分比預計為 - 巴西 8.4%;俄羅斯,5.2%;印度,3.5%;中國,5.9%;南非,10.4%。透過實現更先進的治療替代方案,可以滲透到這些市場,從而擴大斑塊切除設備的全球足跡。
IMARC Group提供了對每個細分市場的主要趨勢的分析,以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據產品、應用和最終用戶對市場進行了分類。
定向斑塊切除裝置
眼眶斑塊旋切裝置
光消融斑塊切除裝置
旋磨術設備
支援設備
定向旋磨設備佔據大部分市場佔有率
該報告根據產品提供了詳細的市場細分和分析。這包括定向斑塊切除裝置、眼眶斑塊切除裝置、光消融斑塊切除裝置、旋轉斑塊切除裝置和支撐裝置。根據該報告,定向斑塊旋切裝置佔據了最大的佔有率。
定向粥樣斑塊切除裝置的創建是為了精確消除阻塞動脈中的動脈粥狀硬化斑塊。這些儀器提供了精確控制的可能性,從而減少了血管壁創傷,這是患者安全和康復的一個重要方面。它們能夠治療多種血管尺寸的複雜病變,使其受到血管專家的青睞,導致該產品領域的成長。該裝置在手術過程中收集和去除牙菌斑的能力使這些裝置與眾不同,並且在許多臨床情況下更受歡迎。
周圍血管
心血管
神經血管
周邊血管佔據大部分市場佔有率
該報告根據應用程式提供了詳細的市場細分和分析。這包括周邊血管、心血管和神經血管。根據報告,周邊血管佔最大部分。
由於 PAD 的盛行率不斷增加,使用斑塊旋切裝置治療周邊血管疾病非常重要。此類裝置在重建腿部動脈血流方面發揮關鍵作用,有助於緩解疼痛和行動問題等症狀。此領域的需求取決於手術的微創特性,與傳統手術相比,微創手術的恢復期短,併發症的風險較低,進而提高病患的治療效果和治療效率。
醫院
門診手術中心
研究實驗室和學術機構
醫院佔大部分市場佔有率
該報告提供了基於最終用戶的詳細市場細分和分析。這包括醫院、門診手術中心、研究實驗室和學術機構。報告稱,醫院佔最大部分。
醫院是斑塊切除設備的主要用戶,因為這些手術非常複雜,需要先進的基礎設施和訓練有素的醫療保健專業人員。此細分市場的成長伴隨著醫院進行的血管手術數量的成長,這得益於對先進技術和醫療服務提供者培訓計劃的投資。醫院提供包括術後要求在內的所有類型護理的能力也有助於使其成為市場的主導主體。
北美洲
美國
加拿大
亞太地區
中國
日本
印度
韓國
澳洲
印尼
其他
歐洲
德國
法國
英國
義大利
西班牙
俄羅斯
其他
拉丁美洲
巴西
墨西哥
其他
中東和非洲
北美市場佔據主導地位
該報告還對包括北美(美國、加拿大)在內的所有主要市場進行了全面分析;亞太地區(中國、日本、印度、韓國、澳洲、印尼等);歐洲(德國、法國、英國、義大利、西班牙、俄羅斯等);拉丁美洲(巴西、墨西哥等)、中東和非洲。報告稱,北美是旋切設備的最大市場。
由於心血管疾病的高發病率、發達的醫療保健系統以及該地區的主要市場參與者,北美成為旋切術的最大市場。美國因其有利的報銷方案、臨床試驗以及政府對先進醫療設備研發的大力支持而成為該地區最大的市場。該地區對應用新醫療保健解決方案的承諾正在推動市場成長。
市場研究報告也對市場競爭格局進行了全面分析。已提供所有主要公司的詳細資料。斑塊旋切設備市場的一些主要市場參與者包括Abbott Laboratories、Avinger、B. Braun Melsungen AG、Biomerics、Biotronik、Boston Scientific Corporation、CR Bard(Becton、Dickinson and Company)、Cardinal Health、Koninklijke Philips NV、Medtronic 、 Minnetronix Inc.、Straub Medical AG(Becton、Dickinson and Company)和 Terumo Corporation。
(請注意,這只是關鍵參與者的部分列表,報告中提供了完整列表。)
斑塊切除設備市場充滿活力,主要參與者採用不斷發展的策略來追求擴大市場佔有率並滿足對微創手術替代方案不斷成長的需求。其中一種方法是以技術為導向的,也就是說,公司在研發方面投入了大量資金,以改善其設備,從而變得更有效率、更安全。第二個共同事件是支持知識共享和更好的分銷管道的策略聯盟和合作。此外,併購很常見,使公司能夠擴大其產品組合和地理覆蓋範圍。監管機構的批准在這裡發揮著重要作用,因為這些公司正在努力滿足嚴格的規範,以確保其產品在許多市場的效率和安全性。
2022 年 3 月,貝朗收購了 Intermedt Medizin & Technik GmbH,一家專門從事透析濃縮液製備的公司。
2023 年 11 月,康德樂宣佈在美國推出帶有 ASSIST 器械袋的 SmartGown EDGE 透氣手術衣,旨在為手術團隊提供手術室中安全、便捷的器械使用。
The global atherectomy devices market size reached US$ 978.0 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,476.0 Million by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032. The rise in peripheral artery disease (PAD), significant technological advancements, rising ageing population, advent of minimally invasive surgeries, development of healthcare infrastructure, and reimbursement policies in emerging economies represent some of the key factors driving the growth of the atherectomy market.
Major Market Drivers: The atherectomy devices market is affected by the increasing cases of peripheral artery disease (PAD) and other cardiovascular diseases. The rising ageing population that is more susceptible to these ailments, along with the rising instances of diabetes, obesity, and smoking, are creating an indirect demand for these devices. Moreover, technological advancements in atherectomy procedures and the growing popularity of minimally invasive surgeries are providing the market with substantial opportunities.
Key Market Trends: The atherectomy devices market is expanding mostly due to significant trends like the increasing cases of PAD and the requirement for minimally invasive surgeries. Advancements in technology enable the production of more advanced devices, which, in turn, give better accuracy and shorter recovery periods. Directional atherectomy systems are also rising in popularity since they allow the user to target and remove atherosclerotic plaque without damaging the vessel wall. In emerging economies, the growth of healthcare infrastructure and better reimbursement situations are propelling atherectomy device availability and usage worldwide.
Competitive Landscape: Some of the major market players in the Atherectomy Devices industry include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), Terumo Corporation, among many others.
Challenges and Opportunities: The atherectomy devices market suffers from several challenges, including high device costs and tough regulatory requirements that cause delays in product launches. On the contrary, market opportunities are also influenced by the growing incidence of peripheral artery diseases and aging population, which lead to the need for efficacious treatment alternatives. Developments in technology which improve the performance and safety of device provide growth opportunity. In addition, the growth of healthcare infrastructure in the emerging markets creates new fronts of market expansion, which stimulates the worldwide demand for atherectomy procedures.
Rising Cases of Peripheral Artery Disease (PAD)
The increasing cases of PAD at a global level due to ageing population and the rise in diabetes and obesity is leading the atherectomy device market growth. Approximately, PAD affects 8 to 12 million people in the United States, especially in those over 50. Out of these, 6.5 million over the age of 40 are diagnosed with PAD. Atherectomy devices provide a minimally invasive approach to remove arterial plaque as it is an important alternative in vascular interventions. The device enhances blood flow and reduces symptoms such as leg pain and fatigue. By directly cutting away or vaporizing the plaque, these devices help restore arterial patency, significantly improving patient outcomes in individuals with severe forms of PAD.
Technological Advancements
Major atherectomy devices innovations include the appearance of directionally controlled devices and high-frequency rotational technologies, which have continued to improve the effectiveness and safety of these devices. For instance, a 2020 study suggests that orbital atherectomy (which sands down plaque) effectively opens up blocked leg arteries 90 percent of the time, while laser atherectomy achieves similarly improved blood flow 76 percent of the time. These improvements in patient outcome and surgeon preference for these devices are propelling the growth of the atherectomy devices. In a multicenter study of 172 patients, Jetstream use had a 99% device success, and six-month and 12-month clinically-driven, target-lesion revascularization rates of 15% and 26%, respectively; with a one-year restenosis rate of 38% based on duplex imaging.
Expansion into Emerging Markets
Prominent key players are focusing on emerging economies where healthcare infrastructure development and growing healthcare spending is focused, thereby creating new opportunities for the key players in the market. For instance, the emerging markets of Brazil, Russia, India, China, and South Africa (BRICS) are increasingly shaping the landscape of the global health sector demand and supply for medical goods and services. Health spending as a percentage of GDP in 2030 is projected as - Brazil, 8.4%; Russia, 5.2%; India, 3.5%; China, 5.9%; South Africa, 10.4%. The penetration into these markets is enabled by realization of more advanced treatment alternatives, thus expanding the global footprint of atherectomy devices.
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels for 2024-2032. Our report has categorized the market based on product, application, and end user.
Directional Atherectomy Devices
Orbital Atherectomy Devices
Photo-Ablative Atherectomy Devices
Rotational Atherectomy Devices
Support Devices
Directional Atherectomy Devices accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the product. This includes directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices. According to the report, directional atherectomy devices represented the largest segment.
Directional atherectomy devices are created to precisely eliminate atherosclerotic plaque from obstructed arteries. These instruments provide the possibility of accurate control, which reduces vessel wall trauma, an important aspect for patient safety and recovery. Their ability to treat complex lesions in multiple vessel sizes makes them to be favoured by vascular specialists leading to the growth of the product segment. The capability of the devices to collect and remove plaque during the procedure sets these devices apart and is in a number of clinical situations preferable.
Peripheral Vascular
Cardiovascular
Neurovascular
Peripheral Vascular accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the application. This includes peripheral vascular, cardiovascular, and neurovascular. According to the report, peripheral vascular represented the largest segment.
The use of atherectomy devices in the treatment of peripheral vascular diseases is important because of the growing prevalence of PAD. Such devices play a key role in reestablishing the blood flow in leg arteries thus help to relieve the symptoms such as pain and mobility problems. The demand in this segment is determined by minimally invasive character of the procedure which allows short recovery period and lower risks of complications in comparison to conventional surgery making patient outcomes and treatment efficiencies higher.
Hospitals
Ambulatory Surgery Centers
Research Laboratories and Academic Institutes
Hospitals accounts for the majority of the market share
The report has provided a detailed breakup and analysis of the market based on the end user. This includes hospitals, ambulatory surgery centers, and research laboratories and academic institutes. According to the report, hospitals represented the largest segment.
Hospitals are the main users of atherectomy devices because these procedures are very complex and need advanced infrastructure and highly trained healthcare professionals. The growth of the segment is followed by the growth of the number of vascular surgeries conducted in hospitals, fueled by investments into advanced technologies and in the training programs of health providers. Ability of hospitals to offer all types of care including post-operative requirements also helps in making them the dominant subject in the market.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America dominates the market
The report has also provided a comprehensive analysis of all the major markets which include North America (United States, Canada); Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others); Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others); Latin America (Brazil, Mexico, Others), and Middle East and Africa. According to the report, North America was the largest market for atherectomy devices.
North America is the largest market for atherectomy because of high prevalence of cardiovascular diseases, developed healthcare system and the key market players in the region. The United States is the biggest market in this region because of the favourable reimbursement scenarios, clinical trials, and solid governmental support for research and development in advanced medical devices. The commitment of the region to application of new healthcare solutions is driving the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have been provided. Some of the major market players in the atherectomy devices market include Abbott Laboratories, Avinger, B. Braun Melsungen AG, Biomerics, Biotronik, Boston Scientific Corporation, C.R. Bard (Becton, Dickinson and Company), Cardinal Health, Koninklijke Philips N.V., Medtronic, Minnetronix Inc., Straub Medical AG (Becton, Dickinson and Company), and Terumo Corporation.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
There is a dynamic market in atherectomy devices with the use of evolving strategies by major players in pursuit to grow their market share and to satisfy the increasing demand for minimally invasive surgery alternatives. One of these approaches is technical oriented, which is to say that the companies invest significantly in R&D to improve their devices that become therefore more efficient and safer. The second common event is strategic alliances and collaborations that support knowledge sharing and better distribution channels. In addition, mergers and acquisitions are common enabling companies to expand their product portfolios and geographical coverage. Approvals by regulatory bodies play an important role here as the companies are trying to meet tough norms that guarantee the efficiency and safety of their products in many markets.
In March 2022, B. Braun acquired Intermedt Medizin & Technik GmbH, a specialist in the preparation of dialysis concentrates.
In November 2023, Cardinal Health announced the U.S. launch of its SmartGown EDGE Breathable Surgical Gown with ASSIST Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.